CAGNACCI, Angelo
 Distribuzione geografica
Continente #
NA - Nord America 41.327
AS - Asia 25.368
EU - Europa 22.808
SA - Sud America 4.397
AF - Africa 463
Continente sconosciuto - Info sul continente non disponibili 29
OC - Oceania 29
Totale 94.421
Nazione #
US - Stati Uniti d'America 40.859
GB - Regno Unito 9.021
CN - Cina 7.643
SG - Singapore 7.119
HK - Hong Kong 3.841
BR - Brasile 3.411
IT - Italia 3.059
VN - Vietnam 2.666
DE - Germania 2.315
SE - Svezia 1.874
UA - Ucraina 1.838
FI - Finlandia 1.412
KR - Corea 1.034
RU - Federazione Russa 955
TR - Turchia 926
FR - Francia 882
BG - Bulgaria 665
IN - India 439
AR - Argentina 376
BD - Bangladesh 350
ID - Indonesia 256
MX - Messico 188
IQ - Iraq 182
EC - Ecuador 173
CA - Canada 146
NL - Olanda 133
ZA - Sudafrica 130
CO - Colombia 121
PK - Pakistan 108
JP - Giappone 103
ES - Italia 99
AE - Emirati Arabi Uniti 91
VE - Venezuela 90
PL - Polonia 86
MA - Marocco 83
IE - Irlanda 82
CL - Cile 80
PH - Filippine 69
SA - Arabia Saudita 59
MY - Malesia 56
LT - Lituania 54
EG - Egitto 53
PY - Paraguay 53
UZ - Uzbekistan 51
KE - Kenya 50
IR - Iran 46
BE - Belgio 39
TN - Tunisia 39
PE - Perù 36
JO - Giordania 33
UY - Uruguay 33
NP - Nepal 31
KZ - Kazakistan 30
CH - Svizzera 29
TH - Thailandia 29
PT - Portogallo 28
RO - Romania 28
AZ - Azerbaigian 27
DZ - Algeria 26
JM - Giamaica 26
DO - Repubblica Dominicana 25
EU - Europa 24
AU - Australia 23
AL - Albania 22
AT - Austria 21
CR - Costa Rica 20
IL - Israele 20
BO - Bolivia 19
CZ - Repubblica Ceca 18
GR - Grecia 17
DK - Danimarca 16
OM - Oman 16
RS - Serbia 16
BH - Bahrain 15
BY - Bielorussia 15
ET - Etiopia 15
TW - Taiwan 15
KG - Kirghizistan 14
LB - Libano 13
PA - Panama 13
QA - Qatar 13
HN - Honduras 12
PS - Palestinian Territory 12
SI - Slovenia 12
GE - Georgia 11
BA - Bosnia-Erzegovina 10
HR - Croazia 10
HU - Ungheria 9
NG - Nigeria 9
SN - Senegal 9
AM - Armenia 8
CY - Cipro 8
LV - Lettonia 8
NI - Nicaragua 8
TT - Trinidad e Tobago 8
CI - Costa d'Avorio 7
KW - Kuwait 7
LY - Libia 7
SK - Slovacchia (Repubblica Slovacca) 7
NZ - Nuova Zelanda 6
Totale 94.299
Città #
Southend 7.074
Singapore 4.335
Jacksonville 4.032
Santa Clara 3.861
Hong Kong 3.790
Fairfield 3.613
Ashburn 3.048
Dearborn 2.598
Hefei 2.590
Woodbridge 2.280
Chandler 2.083
Houston 1.749
Beijing 1.480
Wilmington 1.472
London 1.398
Ann Arbor 1.232
Seattle 1.230
Cambridge 1.149
Nyköping 1.120
Seoul 985
Ho Chi Minh City 903
The Dalles 869
San Jose 798
Helsinki 758
Princeton 758
Sofia 656
Eugene 640
Hanoi 631
Modena 608
Los Angeles 556
Lauterbourg 553
Dallas 445
Izmir 428
Bremen 423
Chicago 397
Buffalo 381
San Diego 371
New York 325
Milan 308
Council Bluffs 297
São Paulo 296
Shanghai 282
Moscow 243
Des Moines 185
Salt Lake City 147
Rome 128
Guangzhou 124
Haiphong 119
Da Nang 106
Norwalk 105
Rio de Janeiro 99
Frankfurt am Main 88
Jakarta 88
Kunming 87
Orem 85
Dublin 79
Columbus 78
Nanjing 77
Tokyo 76
Tampa 68
Baghdad 67
Belo Horizonte 67
Curitiba 64
Brasília 62
Elk Grove Village 62
Chennai 58
Quito 58
Miano 54
Amsterdam 53
Munich 53
Biên Hòa 51
Johannesburg 51
Mexico City 51
San Mateo 51
Guayaquil 50
Hải Dương 50
Dhaka 49
Tashkent 49
Boardman 47
Bologna 44
Dubai 43
Falls Church 43
Verona 43
Jinan 42
Thái Bình 42
Campinas 41
Falkenstein 41
Manchester 41
Nairobi 41
Redwood City 41
Santiago 40
Toronto 40
Warsaw 40
Goiânia 39
Brooklyn 38
Dongguan 38
Lahore 37
Nanchang 37
San Francisco 37
Atlanta 36
Totale 66.675
Nome #
Intensity of menstrual pain and estimated angle of uterine flexion 408
La melatonina aumenta la risposta delle gonadotropine al GnRH nelle donne in fase follicolare precoce, ma non nella fase luteale 406
Menopause, estrogens, progestins, or their combination on body weight and anthropometric measures. 361
Modification of 24-h ambulatory blood pressure and heart rate during contraception with the vaginal ring: a prospective study. 350
Combined oral contraceptive containing drospirenone does not modify 24-h ambulatory blood pressure but increases heart rate in healthy young women: prospective study 339
Impact of laparoscopic cystectomy of endometriotic and non-endometriotic cysts on ovarian volume, antral follicle count (AFC) and ovarian doppler velocimetry 328
Association between urinary incontinence and climacteric symptoms in postmenopausal women 316
Differenza tra forma attiva (5-MTHF) e inattiva (acido folico) di folati sulla vasodilatazione di donne in postmenopausa 312
Intermenstrual pelvic pain, quality of life and mood 312
Adenomyosis of the Extrapelvic Portion of the Round Ligament 309
Are climacteric complaints associated with risk factors of cardiovascular disease in peri-menopausal women? 306
Hereditary Ovarian Cancer: Not Only BRCA 1 and 2 Genes 294
Folate administration decreases oxidative status and blood pressure in postmenopausal women 293
Combined Hormonal Contraceptive Use and Risk of Breast Cancer in a Population of Women With a Family History 292
Relation of folates, vitamin B12 and homocysteine to vertebral bone mineral density change in postmenopausal women. A five-year longitudinal evaluation. 292
Dienogest-based hormonal contraception induced changes in the ultrasound presentation of the uterus and menstrual pain 292
Evaluation of Transvaginal Ultrasound plus CA-125 Measurement and Prophylactic Salpingo-Oophorectomy in Women at Different Risk Levels of Ovarian Cancer: The Modena Study Group Cohort Study 284
Effect of oral contraceptives containing estradiol and nomegestrol acetate or ethinyl-estradiol and chlormadinone acetate on primary dysmenorrhea 282
Reproductive risk factors in women with family history of breast cancer attending an Italian Family Cancer Clinic 280
Body composition and resting metabolic rate of perimenopausal women using continuous progestogen contraception 279
Recommendations for contraception in women with diabetes. AMD-SIC position paper 278
Administration of tibolone decreases 24h heart rate but not blood pressure of post-menopausal women 278
Prediction of age at menopause from assessment of ovarian reserve may be improved by using body mass index and smoking status. 278
Metabolic impact of combined hormonal contraceptives containing estradiol 277
Continuous combined hormone replacement therapy with oral 17β-estradiol and norethisterone acetate improves homocysteine metabolism in postmenopausal women 276
Acute modifications in the levels of daytime melatonin do not influence leptin in postmenopausal women 273
The Association between Endometriomas and Ovarian Cancer: Preventive Effect of Inhibiting Ovulation and Menstruation during Reproductive Life 273
The ovarian response to controlled stimulation in IVF cycles may be predictive of the age at menopause 272
Pelvic Pain and Quality of Life of Women With Endometriosis During Quadriphasic Estradiol Valerate/Dienogest Oral Contraceptive. A Patient-Preference Prospective 24-Week Pilot Study 271
Pharmacokinetic evaluation of desogestrel as a female contraceptive 268
Influence of an oral contraceptive containing drospirenone on insulin sensitivity of healthy women 265
High-dose short-term folate administration modifies ambulatory blood pressure in postmenopausal women. A placebo-controlled study. 264
Relation between oxidative stress and climacteric symptoms in early postmenopausal women 262
Season of birth influences the timing of menopause 260
Melatonin in relation to physiology in adult humans 259
Does dienogest influence the inflammatory response of endometriotic cells? A systematic review 258
Prospective measurement of blood pressure and heart rate over 24 h in women using combined oral contraceptives with estradiol 254
A role for melatonin in PCOS? 249
Medical and patient attitude towards vaginal atrophy: the AGATA study 249
Cyclic progestin administration increases energy expenditure and decreases body fat mass in perimenopausal women 248
Relation between body mass index and endothelium-dependent vasodilatation in healthy postmenopausal women. 247
Effects of melatonin on vascular reactivity, catecholamine levels, and blood pressure in healthy men. 245
Insulin sensitivity and lipid metabolism with oral contraceptives containing chlormadinone acetate or desogestrel: a randomized trial 244
The impact of reproductive life on breast cancer risk in women with family history or BRCA mutation 244
Route of administration of contraceptives containing desogestrel/etonorgestrel and insulin sensitivity: a prospective randomized study. 243
Age at Menopause and Extent of Coronary Artery Disease Among Postmenopausal Women with Acute Coronary Syndromes 243
Amplification of pulsatile LH secretion by exogenous melatonin in women. 241
Prolonged melatonin administration decreases nocturnal blood pressure in women 240
Prevalence and association between objective signs and subjective symptoms of vaginal atrophy: the AGATA study 240
Altered neuroendocrine regulation of luteinizing hormone secretion in postmenopausal women with Parkinson's disease. 240
Conseguenze dell'Isterectomia associata o no ad ovariectomia nella donna 236
Anello Contraccettivo: i vantaggi della somministrazione vaginale 234
Prevalence of menstrual pain in young women: What is dysmenorrhea? 234
Administration of raloxifene does not influence 24-hour ambulatory blood pressure of postmenopausal women with osteopenia: a double-blind placebo-controlled study. 233
Vaginal atrophy of women in postmenopause. Results from amulticentric observational study: The AGATA study 233
Sympathoadrenal response of postmenopausal women prior and during prolonged administration of estradiol 231
Efficacia del nomegestrolo acetato, derivato del 19-Nor progesterone, nel trattamento dei sintomi premestruali: uso in casi selezionati con fase luteale inadeguata 231
Pharmacological, metabolic and clinical aspects of new oral contraceptive associations containing natural estrogens [Aspetti farmacologici, metabolici e clinici delle nuove associazioni contraccettive a base di estrogeni naturali] 230
Influence of exogenous melatonin on catecholamine levels in postmenopausal women prior and during oestradiol replacement. 230
Role of melatonin in circadian rhythm at menopause 229
Hypothermic effect of melatonin and nocturnal core body temperature decline are reduced in aged women. 229
Relation of homocysteine, folate, and vitamin B12 to bone mineral density of postmenopausal women 228
Drospirenone: dati di sicurezza a lungo termine 228
Influence of melatonin and photoperiod on animal and human reproduction 224
Treatment with flutamide improves hyperinsulinemia in women with idiopathic hirsutism. 224
Seasonal trend of acute pelvic inflammatory disease 223
Amplification of pulsatile LH secretion by exogenous melatonin in women 223
Contraccettivi con soli progestinici in perimenopausa.Effetti sul dispendio energetico e composizione corporea 222
Clinical effect of hormonal replacement therapy with estradiol associated with noretisterone or drospirenone. A prospective randomized placebo controlled study 221
Physiological doses of estradiol decrease nocturnal blood pressure in normotensive postmenopausal women. 221
Ovary Cystadenofibroma Associated with Didelphys Uterus in a Teenager: Conservative Laparoscopic Management 220
Melatonin: a major regulator of the circadian rhythm of core temperature in humans. 220
Attitudes and perceptions towards vulvar and vaginal atrophy in Italian post-menopausal women: Evidence from the European REVIVE survey 219
Correlazione tra i livelli di omocisteina e densità minerale ossea in donne in postmenopausa. Uno studio longitudinale 218
Diagnosis and management of symptoms associated with vulvovaginal atrophy: expert opinion on behalf of the Italian VVA study group* 218
Effect of naloxone on body temperature in postmenopausal women with Parkinson's disease. 216
Regulation of the 24-hour rhythm of body temperature in menstrual cycles with spontaneous and gonadotropin-induced ovulation. 216
Hormone replacement therapy and glucose metabolism 216
Effetti dell’ HRT e SERM sulla pressione arteriosa 216
European society of contraception statement on contraception in obese women 216
Fattori implicati nel determinismo del sesso del nascituro 214
Lack of any estrogenic effect of ipriflavone in postmenopausal women. 214
Modification of blood pressure in postmenopausal women: role of hormone replacement therapy 213
Effects of the antidopaminergic drug veralipride on LH and PRL secretion in postmenopausal women. 209
Effects of progestins on estrogen-induced increase in C-reactive protein in postmenopausal women 209
A comparison of the central effects of different progestins used in hormone replacement therapy 209
Melatonin enhances cortisol levels in aged but not young women. 208
Effetto di una terapia ormonale sostitutiva combinata continua contenente noretisterone acetato e del tibolone sulla pressione arteriosa delle 24 h ore 208
“In patient” medical abortion versus surgical abortion: patient’s satisfaction 208
Tibolone and estradiol plus norethisterone acetate similarly influence endothelium-dependent vasodilatation in healthy postmenopausal women 207
Nutrition, Nutriceuticals in older women. 207
The effect of menopause on blood lipid and lipoprotein levels 207
The effect of tibolone on 24h blood pressure and heart rate 206
Estrogeni e ossido nitrico: un sinergismo. 204
Modification of body composition and metabolism during oral contraceptives containing non-androgenic progestins in association with estradiol or ethinyl estradiol 204
Effect of Estradiol valerate plus dienogest on body composition of healthy women in the menopausal transition: A prospective one-year evaluation 204
HRT e apparato cardiovascolare 203
Effects of the dopamine antagonist veralipride on hot flushes and luteinizing hormone secretion in postmenopausal women. 201
Oral contraceptive containing drospirenone and 24-hour ambulatory blood pressare. Preliminare data from a prospective study 201
Blood pressure and cardiovascular risk factors in women treated for climacteric symptoms with acupuncture, phytoestrogens, or hormones 201
Totale 24.950
Categoria #
all - tutte 350.522
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 350.522


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021652 0 0 0 0 0 0 0 0 0 0 356 296
2021/20226.963 130 1.273 483 459 142 334 250 390 941 573 704 1.284
2022/20236.690 972 573 365 449 1.184 1.018 125 616 891 60 225 212
2023/20244.666 201 264 198 332 1.266 515 622 569 74 59 117 449
2024/202515.613 486 186 115 1.142 3.078 2.003 936 720 2.249 1.091 1.169 2.438
2025/202626.785 1.457 1.520 3.988 4.026 2.537 1.818 3.289 1.888 2.599 3.017 646 0
Totale 94.974